Cargando…

Developing a Shared Patient-Centered, Web-Based Medication Platform for Type 2 Diabetes Patients and Their Health Care Providers: Qualitative Study on User Requirements

BACKGROUND: Information technology tools such as shared patient-centered, Web-based medication platforms hold promise to support safe medication use by strengthening patient participation, enhancing patients’ knowledge, helping patients to improve self-management of their medications, and improving...

Descripción completa

Detalles Bibliográficos
Autores principales: Bernhard, Gerda, Mahler, Cornelia, Seidling, Hanna Marita, Stützle, Marion, Ose, Dominik, Baudendistel, Ines, Wensing, Michel, Szecsenyi, Joachim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5893891/
https://www.ncbi.nlm.nih.gov/pubmed/29588269
http://dx.doi.org/10.2196/jmir.8666
_version_ 1783313400104747008
author Bernhard, Gerda
Mahler, Cornelia
Seidling, Hanna Marita
Stützle, Marion
Ose, Dominik
Baudendistel, Ines
Wensing, Michel
Szecsenyi, Joachim
author_facet Bernhard, Gerda
Mahler, Cornelia
Seidling, Hanna Marita
Stützle, Marion
Ose, Dominik
Baudendistel, Ines
Wensing, Michel
Szecsenyi, Joachim
author_sort Bernhard, Gerda
collection PubMed
description BACKGROUND: Information technology tools such as shared patient-centered, Web-based medication platforms hold promise to support safe medication use by strengthening patient participation, enhancing patients’ knowledge, helping patients to improve self-management of their medications, and improving communication on medications among patients and health care professionals (HCPs). However, the uptake of such platforms remains a challenge also due to inadequate user involvement in the development process. Employing a user-centered design (UCD) approach is therefore critical to ensure that user’ adoption is optimal. OBJECTIVE: The purpose of this study was to identify what patients with type 2 diabetes mellitus (T2DM) and their HCPs regard necessary requirements in terms of functionalities and usability of a shared patient-centered, Web-based medication platform for patients with T2DM. METHODS: This qualitative study included focus groups with purposeful samples of patients with T2DM (n=25), general practitioners (n=13), and health care assistants (n=10) recruited from regional health care settings in southwestern Germany. In total, 8 semistructured focus groups were conducted. Sessions were audio- and video-recorded, transcribed verbatim, and subjected to a computer-aided qualitative content analysis. RESULTS: Appropriate security and access methods, supported data entry, printing, and sending information electronically, and tracking medication history were perceived as the essential functionalities. Although patients wanted automatic interaction checks and safety alerts, HCPs on the contrary were concerned that unspecific alerts confuse patients and lead to nonadherence. Furthermore, HCPs were opposed to patients’ ability to withhold or restrict access to information in the platform. To optimize usability, there was consensus among participants to display information in a structured, chronological format, to provide information in lay language, to use visual aids and customize information content, and align the platform to users’ workflow. CONCLUSIONS: By employing a UCD, this study provides insight into the desired functionalities and usability of patients and HCPs regarding a shared patient-centered, Web-based medication platform, thus increasing the likelihood to achieve a functional and useful system. Substantial and ongoing engagement by all intended user groups is necessary to reconcile differences in requirements of patients and HCPs, especially regarding medication safety alerts and access control. Moreover, effective training of patients and HCPs on medication self-management (support) and optimal use of the tool will be a prerequisite to unfold the platform’s full potential.
format Online
Article
Text
id pubmed-5893891
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher JMIR Publications
record_format MEDLINE/PubMed
spelling pubmed-58938912018-04-16 Developing a Shared Patient-Centered, Web-Based Medication Platform for Type 2 Diabetes Patients and Their Health Care Providers: Qualitative Study on User Requirements Bernhard, Gerda Mahler, Cornelia Seidling, Hanna Marita Stützle, Marion Ose, Dominik Baudendistel, Ines Wensing, Michel Szecsenyi, Joachim J Med Internet Res Original Paper BACKGROUND: Information technology tools such as shared patient-centered, Web-based medication platforms hold promise to support safe medication use by strengthening patient participation, enhancing patients’ knowledge, helping patients to improve self-management of their medications, and improving communication on medications among patients and health care professionals (HCPs). However, the uptake of such platforms remains a challenge also due to inadequate user involvement in the development process. Employing a user-centered design (UCD) approach is therefore critical to ensure that user’ adoption is optimal. OBJECTIVE: The purpose of this study was to identify what patients with type 2 diabetes mellitus (T2DM) and their HCPs regard necessary requirements in terms of functionalities and usability of a shared patient-centered, Web-based medication platform for patients with T2DM. METHODS: This qualitative study included focus groups with purposeful samples of patients with T2DM (n=25), general practitioners (n=13), and health care assistants (n=10) recruited from regional health care settings in southwestern Germany. In total, 8 semistructured focus groups were conducted. Sessions were audio- and video-recorded, transcribed verbatim, and subjected to a computer-aided qualitative content analysis. RESULTS: Appropriate security and access methods, supported data entry, printing, and sending information electronically, and tracking medication history were perceived as the essential functionalities. Although patients wanted automatic interaction checks and safety alerts, HCPs on the contrary were concerned that unspecific alerts confuse patients and lead to nonadherence. Furthermore, HCPs were opposed to patients’ ability to withhold or restrict access to information in the platform. To optimize usability, there was consensus among participants to display information in a structured, chronological format, to provide information in lay language, to use visual aids and customize information content, and align the platform to users’ workflow. CONCLUSIONS: By employing a UCD, this study provides insight into the desired functionalities and usability of patients and HCPs regarding a shared patient-centered, Web-based medication platform, thus increasing the likelihood to achieve a functional and useful system. Substantial and ongoing engagement by all intended user groups is necessary to reconcile differences in requirements of patients and HCPs, especially regarding medication safety alerts and access control. Moreover, effective training of patients and HCPs on medication self-management (support) and optimal use of the tool will be a prerequisite to unfold the platform’s full potential. JMIR Publications 2018-03-27 /pmc/articles/PMC5893891/ /pubmed/29588269 http://dx.doi.org/10.2196/jmir.8666 Text en ©Gerda Bernhard, Cornelia Mahler, Hanna Marita Seidling, Marion Stützle, Dominik Ose, Ines Baudendistel, Michel Wensing, Joachim Szecsenyi. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 27.03.2018. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in the Journal of Medical Internet Research, is properly cited. The complete bibliographic information, a link to the original publication on http://www.jmir.org/, as well as this copyright and license information must be included.
spellingShingle Original Paper
Bernhard, Gerda
Mahler, Cornelia
Seidling, Hanna Marita
Stützle, Marion
Ose, Dominik
Baudendistel, Ines
Wensing, Michel
Szecsenyi, Joachim
Developing a Shared Patient-Centered, Web-Based Medication Platform for Type 2 Diabetes Patients and Their Health Care Providers: Qualitative Study on User Requirements
title Developing a Shared Patient-Centered, Web-Based Medication Platform for Type 2 Diabetes Patients and Their Health Care Providers: Qualitative Study on User Requirements
title_full Developing a Shared Patient-Centered, Web-Based Medication Platform for Type 2 Diabetes Patients and Their Health Care Providers: Qualitative Study on User Requirements
title_fullStr Developing a Shared Patient-Centered, Web-Based Medication Platform for Type 2 Diabetes Patients and Their Health Care Providers: Qualitative Study on User Requirements
title_full_unstemmed Developing a Shared Patient-Centered, Web-Based Medication Platform for Type 2 Diabetes Patients and Their Health Care Providers: Qualitative Study on User Requirements
title_short Developing a Shared Patient-Centered, Web-Based Medication Platform for Type 2 Diabetes Patients and Their Health Care Providers: Qualitative Study on User Requirements
title_sort developing a shared patient-centered, web-based medication platform for type 2 diabetes patients and their health care providers: qualitative study on user requirements
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5893891/
https://www.ncbi.nlm.nih.gov/pubmed/29588269
http://dx.doi.org/10.2196/jmir.8666
work_keys_str_mv AT bernhardgerda developingasharedpatientcenteredwebbasedmedicationplatformfortype2diabetespatientsandtheirhealthcareprovidersqualitativestudyonuserrequirements
AT mahlercornelia developingasharedpatientcenteredwebbasedmedicationplatformfortype2diabetespatientsandtheirhealthcareprovidersqualitativestudyonuserrequirements
AT seidlinghannamarita developingasharedpatientcenteredwebbasedmedicationplatformfortype2diabetespatientsandtheirhealthcareprovidersqualitativestudyonuserrequirements
AT stutzlemarion developingasharedpatientcenteredwebbasedmedicationplatformfortype2diabetespatientsandtheirhealthcareprovidersqualitativestudyonuserrequirements
AT osedominik developingasharedpatientcenteredwebbasedmedicationplatformfortype2diabetespatientsandtheirhealthcareprovidersqualitativestudyonuserrequirements
AT baudendistelines developingasharedpatientcenteredwebbasedmedicationplatformfortype2diabetespatientsandtheirhealthcareprovidersqualitativestudyonuserrequirements
AT wensingmichel developingasharedpatientcenteredwebbasedmedicationplatformfortype2diabetespatientsandtheirhealthcareprovidersqualitativestudyonuserrequirements
AT szecsenyijoachim developingasharedpatientcenteredwebbasedmedicationplatformfortype2diabetespatientsandtheirhealthcareprovidersqualitativestudyonuserrequirements